Nektar Therapeutics
NKTR
NKTR
244 hedge funds and large institutions have $2.93B invested in Nektar Therapeutics in 2020 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 79 increasing their positions, 86 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
8% less repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 86
1% less funds holding
Funds holding: 247 → 244 (-3)
Holders
244
Holding in Top 10
–
Calls
$20.8M
Puts
$10.6M
Top Buyers
| 1 | +$16.6M | |
| 2 | +$13.5M | |
| 3 | +$8.66M | |
| 4 |
D.E. Shaw & Co
New York
|
+$7.59M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.46M |
Top Sellers
| 1 | -$29.9M | |
| 2 | -$12.4M | |
| 3 | -$10.4M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$9.83M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$9.68M |